Analyst Price Targets — HOOK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 11, 2022 1:58 pm | — | Leerink Partners | $3.00 | $1.59 | Benzinga | SVB Leerink Maintains Outperform on HOOKIPA Pharma, Lowers Price Target to $3 |
Latest News for HOOK
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HOOK.
U.S. House Trading
No House trades found for HOOK.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.